<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0165">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0165">
  <string-name>
   <surname>Tan</surname>, 
   <given-names>E. L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ooi</surname>, 
   <given-names>E. E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Lin</surname>, 
   <given-names>C. Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Tan</surname>, 
   <given-names>H. C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ling</surname>, 
   <given-names>A. E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Lim</surname>, 
   <given-names>B.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Stanton</surname>, 
   <given-names>L. W.</given-names>
  </string-name> (
  <year>2004</year>). 
  <article-title>Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs</article-title>. 
  <source xml:lang="en">Emerging Infectious Diseases</source>, 
  <volume>10</volume>(
  <issue>4</issue>), 
  <fpage>581</fpage>â€“
  <lpage>586</lpage>. 
  <pub-id pub-id-type="doi">10.3201/eid1004.030458</pub-id>
  <pub-id pub-id-type="pmid">15200845</pub-id>
 </mixed-citation>
</ref>
